Home - Products - Others - Other Targets - Platelet Membrane Glycoprotein IIB Peptide (296-306)

Platelet Membrane Glycoprotein IIB Peptide (296-306)

CAS No. ———

Platelet Membrane Glycoprotein IIB Peptide (296-306)( ——— )

Catalog No. M42053 CAS No. ———

Platelet Membrane Glycoprotein IIB Peptide (296-306)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Platelet Membrane Glycoprotein IIB Peptide (296-306)
  • Note
    Research use only, not for human use.
  • Brief Description
    Platelet Membrane Glycoprotein IIB Peptide (296-306)
  • Description
    Platelet Membrane Glycoprotein IIB Peptide (296-306)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1198.22
  • Molecular Formula
    C47H75N17O20
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Kaempferol 3,7-di-O-...

    Kaempferol-3,7-di-O-β-glucoside (Kaempferol 3,7-diglucoside) is a flavonol from Morettia philaena, It can inhibit α-amylase, α-glucosidase and Acetylcholinesterase. Kaempferol-3, 7-di-o-β-Glucoside has neuroprotective activity and can slow down differentiated neuronal cells SH-SY5Y from Amyloid β peptide-induced damage.

  • NAV-2729

    NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.

  • 4-Hydroxybenzyl alco...

    4-Hydroxybenzyl alcohol exhibits beneficial effects in cerebral ischemic injury, has neuroprotective effect through upregulation of Nrf2, Prdx6, and PDI expression via the PI3K/Akt pathway.